May 7, 2024
James Helzberg
Share
Article Link: https://pubmed.ncbi.nlm.nih.gov/36626622/
What regimens are most effective for induction and maintenance therapy for patients with autoimmune hepatitis?
April 1, 2022
Can POCUS guide volume management in cirrhosis patients with acute kidney injury?
May 18, 2026
Can Efruxifermin Reverse Fibrosis in Compensated MASH Cirrhosis?
April 28, 2026
